Cramer's Lightning Round: RxSight is 'losing too much money'

• It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

U.S. Silica's year-to-date stock performance.

U.S. Silica: "No."

Tetra Tech's year-to-date stock performance.

Tetra Tech: "I will bless it."

RxSight's year-to-date stock performance.

RxSight: "This one's losing a lot of money...I want to do more work on it because they're losing too much money for me to just say it's fine."

Praxis Precision Medicines' year-to-date stock performance.

Praxis Precision Medicines: "It's too risky."

Getty's year-to-date stock performance.

Getty: "The problem is, it's a SPAC...I think you're call is good. At $5, I would actually own that stock. It is all over the place."

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? [e-mail]